Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Income from Continuous Operations of $-19.86M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-19.86M |
|
-- |
|
-- |
|
$20.20M |
|
$-20.20M |
|
$0.35M |
|
$-19.85M |
|
$-19.85M |
|
$-19.86M |
|
|
Income from Continuous Operations |
$-19.86M |
$-19.86M |
|
$-19.86M |
|
$-20.20M |
|
$-20.20M |
|
3.63M |
|
3.63M |
|
$-5.48 |
|
$-5.48 |
|
| Balance Sheet Financials | |
$15.10M |
|
-- |
|
$0.82M |
|
$15.92M |
|
$7.28M |
|
-- |
|
-- |
|
$7.28M |
|
$8.65M |
|
$8.65M |
|
$8.65M |
|
5.87M |
|
| Cash Flow Statement Financials | |
$-24.59M |
|
-- |
|
$25.56M |
|
$13.48M |
|
$14.44M |
|
$0.96M |
|
$2.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.08 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-229.71% |
|
-229.71% |
|
-124.75% |
|
-229.71% |
|
$1.47 |
|
$-6.78 |
|
$-6.78 |
|